Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Australia: Genes ruled unpatentable by High Court

The High Court in D'Arcy v Myriad Genetics [2015] HCA 35 has unanimously found that isolated naturally-occurring nucleic acids coding for mutant or polymorphic genes does did not amount to patentable subject matter in Australia.

The Court overturned the findings of all the lower courts judges and diverged from its own expansive earlier authorities on patentable subject matter, preferring instead to follow US Supreme Court authority on the same case.

The court used emotive arguments in attacking the claim breadth. The majority citing "the chilling effect of the claims ... which would lead to the creation of an exorbitant and unwarranted de facto monopoly…". The jurisprudential reasons for having the patent system and the patentee's right to the broadest possible claim were not given significance.

The basis of rejection of the patent further included "the far reaching questions of public policy ... best left for legislative determination". The Court failed to recognise that its own actions are likely to lead to confusion and uncertainty as to the metes and bounds of the "new gene" patent exclusion.

In a manner reminiscent of US Supreme Court practice, a number of judges also incorporated obviousness arguments into the concept of patentable subject matter.

Of course, the net effect is that it is now more difficult to obtain protection for innovative research in the genetics area, likely leading to the serious consideration of secrecy regimes where protection is no longer available.

Peter Treloar


Shelston IPLevel 21, 60 Margaret StreetSydney NSW 2000AustraliaTel: +61 2 9777 1111Fax: +61 2 9241 4666email@shelstonip.comwww.shelstonip.com

more from across site and ros bottom lb

More from across our site

Civil society and industry representatives met in Geneva on Thursday, September 28 to discuss a potential expansion of the TRIPS waiver
Sources say the beta version of the USPTO’s new trademark search tool is a big improvement over the current system but that it isn’t perfect
Canadian counsel weigh in on the IP office’s decision to raise trademark filing fees in 2024 and how they’re preparing clients
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Shira Perlmutter, US Register of Copyrights, discussed the Copyright Office's role in forming generative AI policy during a House of Representatives hearing
The award marks one of the highest-ever damages received by a foreign company in a trademark infringement suit in China
Two orders denying public access to documents have reignited a debate over a lack of transparency at the new court
Rouse’s new chief of operations and the firm’s CEO tell Managing IP why they think private equity backing will help it conquer Europe
Brian Landry, partner at Saul Ewing, reveals how applicants can prosecute patent applications in the wake of the Federal Circuit's In re Cellect ruling
Ronelle Geldenhuys of Australia’s Foundry IP considers the implications complex computer technologies such as AI have on decision-making